RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)
Go back to RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.24 +0.34 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.90 | 52 Week High | $108.96 | |||
| Open | $55.80 | 52 Week Low | $62.12 | |||
| Day High | $56.73 | P/E | N/A | |||
| Day Low | $55.74 | EPS | $-1.27 | |||
| Volume | 254,498 | |||||
| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||
